Palvella Therapeutics (PVLA) Revenue (2016 - 2024)
Historic Revenue for Palvella Therapeutics (PVLA) over the last 11 years, with Q4 2024 value amounting to -$181000.0.
- Palvella Therapeutics' Revenue fell 11393.38% to -$181000.0 in Q4 2024 from the same period last year, while for Dec 2024 it was -$128000.0, marking a year-over-year decrease of 10029.83%. This contributed to the annual value of -$430000.0 for FY2024, which is 10100.44% down from last year.
- Palvella Therapeutics' Revenue amounted to -$181000.0 in Q4 2024, which was down 11393.38% from $53000.0 recorded in Q1 2024.
- In the past 5 years, Palvella Therapeutics' Revenue ranged from a high of $20.1 million in Q2 2023 and a low of -$181000.0 during Q4 2024
- Its 5-year average for Revenue is $7.1 million, with a median of $4.7 million in 2021.
- Per our database at Business Quant, Palvella Therapeutics' Revenue skyrocketed by 44315.85% in 2023 and then tumbled by 11393.38% in 2024.
- Quarter analysis of 5 years shows Palvella Therapeutics' Revenue stood at $1.9 million in 2020, then surged by 349.81% to $8.4 million in 2021, then tumbled by 30.76% to $5.8 million in 2022, then tumbled by 77.78% to $1.3 million in 2023, then crashed by 113.93% to -$181000.0 in 2024.
- Its Revenue stands at -$181000.0 for Q4 2024, versus $53000.0 for Q1 2024 and $1.3 million for Q4 2023.